1-3 of 3
Maria Engström
Close
Sort by
Journal Articles

Maintenance Treatment with 5-Azacitidine for Patients with High Risk Myelodysplastic Syndr–ome (MDS) or Acute Myeloid Leukemia Following MDS (MDS-AML) in Complete Remission (CR) after Induction Chemotherapy

Michael Grövdal, Rasheed Khan, Anni Aggerholm, Petar Antunovic, Jan Astermark, Per Bernell, Lena-Maria Engström, Lars Kjeldsen, Olle Linder, Lars Nilsson, Anna Olsson, Jonas Wallvik, Jon Magnus Tangen, Gunnar Öberg, Sten Eirik Jacobsen, Anna Porwit, Peter Hokland, Eva Hellström-Lindberg
Journal: Blood
Blood (2008) 112 (11): 223.
https://doi.org/10.1182/blood.V112.11.223.223
Published: 2008
Journal Articles

Maintenance Treatment with Azacytidine for Patients with High Risk Myelodysplastic Syndromes or Acute Myeloid Leukaemia in Complete Remission after Intensive Chemotherapy.

Michael Grövdal, Rasheed Khan, Anni Aggerholm, Petar Antunovic, Jan Astermark, Per Bernell, Lena-Maria Engström, Lars Kjeldsen, Olle Linder, Lars Nilsson, Anna Olsson, Jonas Wallvik, Jon Magnus Tangen, Gunnar Öberg, Sten Eirik Jacobsen, Peter Hokland, Anna Porwit, Eva Hellström-Lindberg
Journal: Blood
Blood (2007) 110 (11): 818.
https://doi.org/10.1182/blood.V110.11.818.818
Published: 2007
Journal Articles

Stem cell factor promotes mast cell survival via inactivation of FOXO3a-mediated transcriptional induction and MEK-regulated phosphorylation of the proapoptotic protein Bim

Christine Möller, Jessica Alfredsson, Maria Engström, Hanna Wootz, Zou Xiang, Johan Lennartsson, Jan-Ingvar Jönsson, Gunnar Nilsson
Journal: Blood
Blood (2005) 106 (4): 1330–1336.
https://doi.org/10.1182/blood-2004-12-4792
Published: 2005